Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.7850
+0.1059 (15.59%)
At close: Oct 9, 2025, 4:00 PM EDT
0.7080
-0.0770 (-9.81%)
Pre-market: Oct 10, 2025, 5:41 AM EDT

RVPH Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Cash & Equivalents
10.3613.4823.3718.5229.698.76
Upgrade
Cash & Short-Term Investments
10.3613.4823.3718.5229.698.76
Upgrade
Cash Growth
67.75%-42.33%26.17%-37.62%238.89%-85.63%
Upgrade
Other Current Assets
0.451.210.330.41.720
Upgrade
Total Current Assets
10.8214.6823.718.9231.48.76
Upgrade
Other Long-Term Assets
0.820.82----
Upgrade
Total Assets
11.6315.523.718.9231.48.76
Upgrade
Accounts Payable
4.976.283.853.520.511.01
Upgrade
Accrued Expenses
77.8613.336.44--
Upgrade
Short-Term Debt
0.110.46----
Upgrade
Other Current Liabilities
----1.840.32
Upgrade
Total Current Liabilities
12.0814.617.189.962.341.33
Upgrade
Other Long-Term Liabilities
0.020.090.810.570.371.96
Upgrade
Total Long-Term Liabilities
0.020.090.810.570.371.96
Upgrade
Total Liabilities
12.0914.6917.9810.532.723.3
Upgrade
Common Stock
0.0100000
Upgrade
Additional Paid-in Capital
176.29165.08140.07103.4995.5263.77
Upgrade
Retained Earnings
-176.76-164.27-134.35-95.09-66.83-58.31
Upgrade
Shareholders' Equity
-0.460.815.728.3928.695.47
Upgrade
Total Liabilities & Equity
11.6315.523.718.9231.48.76
Upgrade
Total Debt
0.110.460000
Upgrade
Net Cash (Debt)
10.2513.0223.3718.5229.698.76
Upgrade
Net Cash Growth
-21.26%-44.29%26.17%-37.62%238.89%-85.45%
Upgrade
Net Cash Per Share
0.240.390.980.952.012.86
Upgrade
Book Value
-0.460.815.728.3928.695.47
Upgrade
Book Value Per Share
-0.010.020.240.431.941.79
Upgrade
Tangible Book Value
-0.460.815.728.3928.695.47
Upgrade
Tangible Book Value Per Share
-0.010.020.240.431.941.79
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q